⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19679434 | 0.88 | TP53 (0.37) | — | |
| SCHEMBL277768 | 0.83 | ADH1B (0.32) | — | |
| SCHEMBL27277772 | 0.80 | TP53 (0.35) | — | |
| SCHEMBL12661555 | 0.79 | TP53 (0.39) | — | |
| SCHEMBL21037151 | 0.79 | TP53 (0.39) | — | |
| SCHEMBL23870326 | 0.78 | KDM4E (0.33) | — | |
| SCHEMBL31008668 | 0.78 | — | — | |
| SCHEMBL12040164 | 0.77 | — | — | |
| SCHEMBL3153787 | 0.77 | ANPEP (0.40) | — | |
| SCHEMBL19673778 | 0.77 | ANPEP (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024140700-A1 | BENZOTHIAZOLE COMPOUND, AND SYNTHESIS THEREFOR AND USE THEREOF | 西北农林科技大学 | 2024-07-04 | — | — | WO | disclosed |
| US-12018267-B2 | Plants having increased tolerance to herbicides | BASF SE (DE) | 2024-06-25 | — | — | US | disclosed |
| US-11992012-B2 | Diaminotriazine compounds | BASF SE (DE) | 2024-05-28 | — | — | US | disclosed |
| EP-4370505-A1 | HERBICIDAL PHENYLURACILS | BASF SE (DE) | 2024-05-22 | — | — | EP | disclosed |
| US-11965171-B2 | Plants having increased tolerance to herbicides | BASF SE (DE) | 2024-04-23 | — | — | US | disclosed |
| CN-117897378-A | Plants with increased tolerance to herbicides | 巴斯夫农业种子解决方案美国有限责任公司 | 2024-04-16 | — | — | CN | disclosed |
| US-11939587-B2 | Plants having increased tolerance to herbicides | BASF SE (DE) | 2024-03-26 | — | — | US | disclosed |
| CN-117751102-A | Herbicidal phenyluracils | 巴斯夫欧洲公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117143092-A | Benzothiazole compound and synthesis and application thereof | 西北农林科技大学 | 2023-12-01 | — | — | CN | disclosed |
| US-20230345941-A1 | HERBICIDAL PHENYLETHERS | BASF SE (DE) | 2023-11-02 | — | — | US | disclosed |
| WO-2013092856-A1 | PROCESS FOR MANUFACTURING BENZOXAZINONES | BASF SE (DE) | 2013-06-27 | — | — | WO | disclosed |
| WO-2013092859-A1 | PROCESS FOR MANUFACTURING 4-SUBSTITUTED AMINO-BENZOXAZINONES | BASF SE (DE) | 2013-06-27 | — | — | WO | disclosed |
| WO-2013092850-A1 | PROCESS FOR MANUFACTURING ARYLOXYACETAMIDES | BASF SE (DE) | 2013-06-27 | — | — | WO | disclosed |
| US-20130053376-A1 | NOVEL TYROSINE KINASE INHIBITORS | CHEMBRIDGE COPRPORATION | 2013-02-28 | — | — | US | disclosed |
| US-20130053376-A1 | NOVEL TYROSINE KINASE INHIBITORS | CHEMBRIDGE COPRPORATION | 2013-02-28 | — | — | US | disclosed |
| US-20120071473-A1 | TRICYCLIC COMPOUND DERIVATIVES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY DISORDERS AND IMMUNOMODULATORY DISORDERS | CHEMBRIDGE CORPORATION | 2012-03-22 | — | — | US | disclosed |
| US-20120065233-A1 | TYROSINE KINASE INHIBITORS | GREGOR VLAD EDWARD (US) | 2012-03-15 | — | — | US | disclosed |
| US-8063225-B2 | 2-(4-(3-(2,4-Dimethylphenoxy)-2-hydroxypropylamino)-2-oxo-1,2-dihydropyridin-3-yl)-6-(1-methylpiperidin-4-yl)-6,7-dihydroimidazo[4,5-f]isoindol-5(1H)-one; modulating tyrosine kinase; enzyme inhibitors; cancer, diabetes, restenosis, arteriosclerosis, psoriasis, angiogenic diseases, immunologic disorders | CHEMBRIDGE CORPORATION (US) | 2011-11-22 | — | — | US | disclosed |
| US-7550481-B2 | Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer's disease | MERCK & CO., INC. (US) | 2009-06-23 | — | — | US | disclosed |
| US-20080171769-A1 | Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders | CHEMBRIDGE CORPORATION | 2008-07-17 | — | — | US | disclosed |